Literature DB >> 16865090

Matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria.

Philippe E Van den Steen1, Ilse Van Aelst, Sofie Starckx, Klaus Maskos, Ghislain Opdenakker, Axel Pagenstecher.   

Abstract

Cerebral malaria (CM) is a life-threatening disorder and a major medical problem in developing countries. It is caused by the sequestration of malaria-infected erythrocytes onto brain endothelia, followed by blood-brain barrier (BBB) damage and neurological deficit. In the present study, matrix metalloproteinases (MMPs) were analysed in a mouse model of CM with Plasmodium berghei ANKA. Increased numbers of gelatinase B (MMP-9)-positive cells, which were also CD11b(+), were detected in the brain. In addition, activation of gelatinase B occurred in CM brains, and not in brains of mice with non-CM. However, selective genetic knockout of gelatinase B did not alter the clinical evolution of experimental CM. To study other protease balances, the mRNA expression levels of nine matrix metalloproteinases (MMPs), five membrane-type MMPs, TNF-alpha converting enzyme (TACE) and the four tissue inhibitors of metalloproteinases (TIMPs) were analysed during CM in different organs. Significant alterations in expression were observed, including increases of the mRNAs of MMP-3, -8, -13 and -14 in the spleen, MMP-8, -12, -13 and -14 in the liver and MMP-8 and -13 in the brain. Net gelatinolytic activity, independent of gelatinase B and inhibitable with EDTA, was detected in situ in the endothelia of blood vessels in CM brains, but not in brains of mice with non-CM, suggesting that metalloproteases, different from gelatinase B, are active in the BBB environment in CM. The increase in MMP expression in the brain was significantly less pronounced after infection of C57Bl/6 mice with the noncerebral strain P. berghei NK65, but it was similar in CM-susceptible C57Bl/6 and CM-resistant Balb/C mice upon infection with P. berghei ANKA. Furthermore, in comparison with C57Bl/6 mice, a larger increase in TIMP-1 and a marked, >30-fold induction in MMP-3 were found in the brains of Balb/C mice, suggesting possible protective roles for TIMP-1 and MMP-3.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865090     DOI: 10.1038/labinvest.3700454

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  23 in total

Review 1.  Zymography methods for visualizing hydrolytic enzymes.

Authors:  Jennifer Vandooren; Nathalie Geurts; Erik Martens; Philippe E Van den Steen; Ghislain Opdenakker
Journal:  Nat Methods       Date:  2013-03       Impact factor: 28.547

2.  Involvement of inflammatory chemokines in survival of human monocytes fed with malarial pigment.

Authors:  Giuliana Giribaldi; Mauro Prato; Daniela Ulliers; Valentina Gallo; Evelin Schwarzer; Oskar B Akide-Ndunge; Elena Valente; Silvia Saviozzi; Raffaele A Calogero; Paolo Arese
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

Review 3.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

4.  Long-term expression of tissue-inhibitor of matrix metalloproteinase-1 in the murine central nervous system does not alter the morphological and behavioral phenotype but alleviates the course of experimental allergic encephalomyelitis.

Authors:  Gioia E M Althoff; David P Wolfer; Nina Timmesfeld; Benoit Kanzler; Heinrich Schrewe; Axel Pagenstecher
Journal:  Am J Pathol       Date:  2010-06-17       Impact factor: 4.307

5.  Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol.

Authors:  Yuri C Martins; Guilherme L Werneck; Leonardo J Carvalho; Beatriz P T Silva; Bruno G Andrade; Tadeu M Souza; Diogo O Souza; Cláudio T Daniel-Ribeiro
Journal:  Malar J       Date:  2010-03-24       Impact factor: 2.979

6.  Deletion of the complement phagocytic receptors CR3 and CR4 does not alter susceptibility to experimental cerebral malaria.

Authors:  T N Ramos; D C Bullard; S R Barnum
Journal:  Parasite Immunol       Date:  2012-11       Impact factor: 2.280

Review 7.  Glial activation and matrix metalloproteinase release in cerebral malaria.

Authors:  A Szklarczyk; M Stins; E A Milward; H Ryu; C Fitzsimmons; D Sullivan; K Conant
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

8.  Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria.

Authors:  Mario Dell'agli; Germana V Galli; Michela Bulgari; Nicoletta Basilico; Sergio Romeo; Deepak Bhattacharya; Donatella Taramelli; Enrica Bosisio
Journal:  Malar J       Date:  2010-07-19       Impact factor: 2.979

9.  Matrix Metalloproteinase-9 and Haemozoin: Wedding Rings for Human Host and Plasmodium falciparum Parasite in Complicated Malaria.

Authors:  Mauro Prato; Giuliana Giribaldi
Journal:  J Trop Med       Date:  2011-05-26

10.  Neuroimmunological blood brain barrier opening in experimental cerebral malaria.

Authors:  Adela Nacer; Alexandru Movila; Kerstin Baer; Sebastian A Mikolajczak; Stefan H I Kappe; Ute Frevert
Journal:  PLoS Pathog       Date:  2012-10-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.